Direct Answer
The Nasdaq Biotechnology Index is a rule-based measurement of nasdaq-listed biotechnology/pharma benchmark, maintained by Nasdaq. Like every index it owns nothing: it is a number produced by applying a published weighting formula to a selected list of companies, revised on a schedule the provider sets.
What this index covers
The Nasdaq Biotechnology Index covers nasdaq-listed biotechnology/pharma benchmark, within the United States market. Nasdaq defines which securities are eligible, how they are selected from that pool, and how much each one contributes to the published number.
The index name does not state a fixed company count, so the number of constituents follows the eligibility rules rather than a target.
How constituents are weighted
Swoopr has not verified the weighting method for this index against Nasdaq's current methodology document, so none is stated here rather than guessed. The provider link below is authoritative.
Current Nasdaq Biotechnology Index constituents
Nasdaq publishes and licenses the Nasdaq Biotechnology Index constituent list. Swoopr does not republish it here. The provider's own page is the authoritative source for current membership and weights.
Related reading
- All stock market indexes: how indexes are built, weighted and revised.
- United States indexes: others covering the same region.
- Index concentration: measuring how much of an index sits in its largest holdings.
- Index rebalancing and inclusion effects: what happens to a stock when index membership changes.
Frequently Asked Questions
Who maintains the Nasdaq Biotechnology Index?
Nasdaq maintains the Nasdaq Biotechnology Index and publishes the methodology document that defines its eligibility and weighting rules.
What does the Nasdaq Biotechnology Index measure?
It measures nasdaq-listed biotechnology/pharma benchmark. The index is a calculated number applying a weighting formula to a selected list of companies, and it holds nothing itself.
Where can I see the current Nasdaq Biotechnology Index constituents?
Nasdaq publishes the current constituent list. Swoopr does not republish it, because index providers license constituent data and Swoopr holds no such licence.